Takeda Pharmaceutical Company Limited Derivative Financial Liabilities
Takeda Pharmaceutical Company Limited (TKPHF) had Derivative Financial Liabilities of JPY 16.53 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes › Derivative Instruments and Hedging Activities
ifrs-full:DerivativeFinancialLiabilities · last filed 2025-06-25
- 2025-03-31: Derivative Financial Liabilities 16.53B JPY.
- 2024-03-31: Derivative Financial Liabilities 25.11B JPY.
- 2023-03-31: Derivative Financial Liabilities 40.72B JPY.
- 2022-03-31: Derivative Financial Liabilities 36.53B JPY.
| Period end | Derivative Financial Liabilities |
|---|---|
| 2025-03-31 | 16.53B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 25.11B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 40.72B JPY 20-F · filed 2024-06-26 |
| 2022-03-31 | 36.53B JPY 20-F · filed 2023-06-28 |
| 2021-03-31 | 97.09B JPY 20-F · filed 2022-06-29 |
| 2020-03-31 | 52.59B JPY 20-F · filed 2021-06-29 |
| 2019-03-31 | 8.74B JPY 20-F · filed 2020-06-24 |
| 2018-03-31 | 8.87B JPY 20-F · filed 2019-06-27 |